Sarah Bathers

1.5k total citations
22 papers, 862 citations indexed

About

Sarah Bathers is a scholar working on Oncology, Surgery and Economics and Econometrics. According to data from OpenAlex, Sarah Bathers has authored 22 papers receiving a total of 862 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 6 papers in Surgery and 6 papers in Economics and Econometrics. Recurrent topics in Sarah Bathers's work include Bladder and Urothelial Cancer Treatments (5 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers) and Breast Cancer Treatment Studies (5 papers). Sarah Bathers is often cited by papers focused on Bladder and Urothelial Cancer Treatments (5 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers) and Breast Cancer Treatment Studies (5 papers). Sarah Bathers collaborates with scholars based in United Kingdom, Australia and Switzerland. Sarah Bathers's co-authors include D. Michael A. Wallace, Angela Risch, Edith Sim, Janet Dunn, Richard T. Bryan, S. Bowden, Gulnaz Begum, Robert Grieve, Indrajit Fernando and Daniel Rea and has published in prestigious journals such as Journal of Clinical Oncology, Human Molecular Genetics and British Journal of Cancer.

In The Last Decade

Sarah Bathers

18 papers receiving 840 citations

Peers

Sarah Bathers

ONCOL

SURGE

GENET

PRM

Maya Charafeddine Lebanon

J Robert Canada

H. Hamed United Kingdom

Mindaugas Jievaltas Lithuania

MaryBeth B. Culp United States

Fabio Levi Italy

Angela S. Wenzlaff United States

H. J. de Voogt Netherlands

D.W.W. Newling Netherlands

Dominic Varga Germany

Maya Charafeddine Lebanon

Sarah Bathers

297 ×0.8

647 ×1.9

ONCOL

130 ×0.6

SURGE

146 ×0.7

GENET

166 ×0.9

PRM

Citations per year, relative to Sarah Bathers Sarah Bathers (= 1×) peers Maya Charafeddine

Countries citing papers authored by Sarah Bathers

Since Specialization

Citations

This map shows the geographic impact of Sarah Bathers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Bathers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Bathers more than expected).

Fields of papers citing papers by Sarah Bathers

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Bathers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Bathers. The network helps show where Sarah Bathers may publish in the future.

Co-authorship network of co-authors of Sarah Bathers

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Bathers. A scholar is included among the top collaborators of Sarah Bathers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Bathers. Sarah Bathers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Geraghty, Adam W A, Taeko Becque, Lisa Roberts, et al.. (2025). Supporting self-management with an internet intervention for low back pain in primary care: a RCT (SupportBack 2). Health Technology Assessment. 29(7). 1–90.

Bathers, Sarah, Laurna Bullock, Andrea Cherrington, et al.. (2024). Protocol for a trial-based economic evaluation analysis of a complex digital health intervention including a computerised decision support tool: the iFraP intervention. NIHR Open Research. 4. 15–15.

Bullock, Laurna, Andrea Cherrington, Emma Clark, et al.. (2024). Protocol for a mixed methods process evaluation for a randomised controlled trial to improve shared decision-making about, and uptake of, osteoporosis medicines: the iFraP study. NIHR Open Research. 4. 70–70.

Littlewood, Chris, Marcus Bateman, Sarah Bathers, et al.. (2020). Rehabilitation following rotator cuff repair: A multi-centre pilot & feasibility randomised controlled trial (RaCeR). Clinical Rehabilitation. 35(6). 829–839. 11 indexed citations

Geraghty, Adam W A, Jonathan Hill, Nadine E. Foster, et al.. (2020). Supporting self-management of low back pain with an internet intervention in primary care: a protocol for a randomised controlled trial of clinical and cost-effectiveness (SupportBack 2). BMJ Open. 10(8). e040543–e040543. 5 indexed citations

Hind, Daniel, Barnaby C Reeves, Sarah Bathers, et al.. (2017). Comparative costs and activity from a sample of UK clinical trials units. Trials. 18(1). 203–203. 15 indexed citations

Bryan, Richard T., Tim Evans, Janet Dunn, et al.. (2015). A Comparative Analysis of the Influence of Gender, Pathway Delays, and Risk Factor Exposures on the Long-term Outcomes of Bladder Cancer. European Urology Focus. 1(1). 82–89. 13 indexed citations

Gray, Richard, Daniel Rea, Kelly Handley, et al.. (2013). aTTom: Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years in 6,953 women with early breast cancer.. Journal of Clinical Oncology. 31(15_suppl). 5–5. 50 indexed citations

Spooner, D., Deborah Stocken, Sarah Bathers, et al.. (2012). A Randomised Controlled Trial to Evaluate both the Role and the Optimal Fractionation of Radiotherapy in the Conservative Management of Early Breast Cancer. Clinical Oncology. 24(10). 697–706. 22 indexed citations

10.

Earl, Helena, Louise Hiller, Janet Dunn, et al.. (2008). NEAT: National Epirubicin Adjuvant Trial – toxicity, delivered dose intensity and quality of life. British Journal of Cancer. 99(8). 1226–1231. 13 indexed citations

11.

Hiller, Louise, et al.. (2007). Questioning specialists’ attitudes to breast cancer follow-up in primary care. Annals of Oncology. 18(9). 1467–1476. 49 indexed citations

12.

Earl, Helena, Louise Hiller, Janet Dunn, et al.. (2007). The National Epirubicin Adjuvant Trial (NEAT) and Scottish Cancer Trials Breast Group (SCTBG) br9601 randomized phase III adjuvant early breast cancer trials: The updated definitive joint analysis. Journal of Clinical Oncology. 25(18_suppl). 534–534. 1 indexed citations

13.

Rea, Daniel, Louise Hiller, Helena Earl, et al.. (2004). Tolerability and efficacy of classical CMF (cCMF) using oral cyclophosphamide (OC) vs intravenous cyclophosphamide (IVC) in early stage breast cancer: A non-randomised comparison of patients (pts) treated in the National Epirubicin Adjuvant Trial (NEAT). Journal of Clinical Oncology. 22(14_suppl). 595–595. 2 indexed citations

14.

Begum, Gulnaz, Janet Dunn, Richard T. Bryan, Sarah Bathers, & D. Michael A. Wallace. (2004). Socio‐economic deprivation and survival in bladder cancer. British Journal of Urology. 94(4). 539–543. 17 indexed citations

15.

Rea, D., Louise Hiller, Helena Earl, et al.. (2004). Tolerability and efficacy of classical CMF (cCMF) using oral cyclophosphamide (OC) vs intravenous cyclophosphamide (IVC) in early stage breast cancer: A non-randomised comparison of patients (pts) treated in the National Epirubicin Adjuvant Trial (NEAT). Journal of Clinical Oncology. 22(14_suppl). 595–595.

16.

Wallace, D. Michael A., Richard T. Bryan, Janet Dunn, Gulnaz Begum, & Sarah Bathers. (2002). Delay and survival in bladder cancer. British Journal of Urology. 89(9). 868–878. 114 indexed citations

17.

Billingham, Lucinda, Sarah Bathers, Andrea Burton, Stirling Bryan, & M.H. Cullen. (2002). Patterns, costs and cost-effectiveness of care in a trial of chemotherapy for advanced non-small cell lung cancer. Lung Cancer. 37(2). 219–225. 21 indexed citations

18.

Cooke, Peter, Janet Dunn, T. Latief, et al.. (2000). Long–Term Risk of Salvage Cystectomy after Radiotherapy for Muscle–Invasive Bladder Cancer. European Urology. 38(3). 279–286. 21 indexed citations

19.

Risch, Angela, D. Michael A. Wallace, Sarah Bathers, & Edith Sim. (1995). Slow N-acetylation genotype is a susceptibility factor in occupational and smoking related bladder cancer. Human Molecular Genetics. 4(2). 231–236. 181 indexed citations

20.

Lynch, Thomas, et al.. (1993). Treatment Preferences of Urologists in Great Britain and Ireland in the Management of Prostate Cancer. British Journal of Urology. 71(5). 577–582. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact